EUVIMEDEUVIMED entdecken
Crossref

Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up

Michinori Funato, Reina Iwata, Toru Ando, Motohiro Takeuchi, Yohei Horibe, Takashi Funato, Junko Oota, Ryoya Uno, Misaki Yumioka, Emi Kondo, Miho Katoyama, Chie Ito und 3 weitere

Brain and Development · 2025-02 · 47 (1) · 104297

DOI: 10.1016/j.braindev.2024.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Development, 2025-02. Verfasst von Michinori Funato und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, NHO Nagara Medical Center, Gifu, Japan. Electronic address: mfunato@mac.com. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Oligonucleotides, Oligonucleotides, Antisense. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneOligonucleotidesOligonucleotides, AntisenseHumansChildRetrospective StudiesAdolescentMaleYoung AdultFollow-Up StudiesTreatment Outcome

Stichwörter der Autor:innen

Antisense oligonucleotide, safetyDuchenne muscular dystrophyExon 53 skippingViltolarsen

Substanzen

OligonucleotidesOligonucleotides, Antisense

Autor:innen und Institutionen

  • Department of Pediatric Neurology, NHO Nagara Medical Center, Gifu, Japan. Electronic address: mfunato@mac.com.
  • Department of Pharmacy, NHO Nagara Medical Center, Gifu, Japan.
  • Ando Pediatrics, Tsuruga, Japan.
  • Department of Pediatrics, NHO Tsuruga Medical Center, Tsuruga, Japan.
  • Horibe Clinic, Motosu, Japan.
  • Funato Clinic, Yoro, Japan.

Zitieren

APA

Funato, M., Iwata, R., Ando, T., Takeuchi, M., Horibe, Y., Funato, T., Oota, J., Uno, R., Yumioka, M., Kondo, E., Katoyama, M., Ito, C., Kato, Y., Yamada, Y., & Kusukawa, T. (2025). Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up. Brain and Development, 47(1), 104297. https://doi.org/10.1016/j.braindev.2024.10.005

Vancouver

Funato M, Iwata R, Ando T, Takeuchi M, Horibe Y, Funato T, et al. Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up. Brain and Development. 2025;47(1):104297. doi:10.1016/j.braindev.2024.10.005

BibTeX
@article{Funato2025,
  author = {Funato, Michinori and Iwata, Reina and Ando, Toru and Takeuchi, Motohiro and Horibe, Yohei and Funato, Takashi and Oota, Junko and Uno, Ryoya and Yumioka, Misaki and Kondo, Emi and Katoyama, Miho and Ito, Chie and Kato, Yoshiko and Yamada, Yuji and Kusukawa, Toshifumi},
  title = {Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up},
  journal = {Brain and Development},
  year = {2025},
  volume = {47},
  number = {1},
  pages = {104297},
  doi = {10.1016/j.braindev.2024.10.005}
}
Kostenlos starten →